MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- FDA approves inebilizumab, now Uplizna, to treat adults with gMG
by Marisa Wexler, MS on December 12, 2025 at 1:00 pmThe U.S. Food and Drug Administration (FDA) has approved inebilizumab as a treatment for generalized myasthenia gravis (gMG). The newly approved therapy, which developer Amgen will market under the brand name Uplizna, is specifically indicated for adults with gMG who are positive for antibodies targeting the acetylcholine receptor (AChR) or muscle-specific kinase (MuSK). These are The post FDA approves inebilizumab, now Uplizna, to treat adults with gMG appeared first on Myasthenia Gravis News.
- Getting a generalized MG diagnosis can take more than 2 years: Study
by Marisa Wexler, MS on December 11, 2025 at 3:15 pmFor people with generalized myasthenia gravis (MG) in the U.S., getting a correct diagnosis is often a difficult and stressful process that can take more than two years from the time of symptom onset, a study showed. Findings suggest that people with MG often feel dismissed by doctors when they first seek care, especially those The post Getting a generalized MG diagnosis can take more than 2 years: Study appeared first on Myasthenia Gravis News.
- Reexamining doctor-patient relationships with more compassion
by Sarah Bendiff on December 11, 2025 at 3:00 pmIn many cultures, being a doctor is considered the ultimate sign of success, as is the case here in Algeria. As a child, I looked up to doctors, whom I viewed as heroes, with their white coats and calm voices. These people had the power to save lives. But because of myasthenia gravis (MG), I The post Reexamining doctor-patient relationships with more compassion appeared first on Myasthenia Gravis News.
- Foundation creates digital guide to decode medical jargon in MG
by Marisa Wexler, MS on December 9, 2025 at 6:00 pmThe Myasthenia Gravis Foundation of America (MGFA) has published a new resource designed to help people with myasthenia gravis (MG) understand the medical jargon and terminology that’s commonly used to discuss the disease. The MG Lexicon offers succinct definitions for a wide range of terms. The definitions are listed alphabetically by term, but the online The post Foundation creates digital guide to decode medical jargon in MG appeared first on Myasthenia Gravis News.
- Thoughtful gift ideas for someone with myasthenia gravis
by Shawna Barnes on December 8, 2025 at 3:00 pmIf you’re shopping for someone with myasthenia gravis (MG), choosing the right gift can feel a little like trying to guess what kind of weather you’ll get tomorrow — unpredictable with a chance of “my body said nope.” MG is a rare condition that affects muscle strength, so help, comfort, and a touch of joy The post Thoughtful gift ideas for someone with myasthenia gravis appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.